Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

EGFR E746_A750del

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

EGFR E746_A750del	Non Small Cell Lung Cancer	EGFR E746_A750del	Non Small Cell Lung Cancer	erlotinib Sensitive: C3 – Early Trials erlotinib Sensitive : C3	erlotinib Sensitive: C3 – Early Trials erlotinib Sensitive : C3
EGFR E746_A750del	Non Small Cell Lung Cancer	EGFR E746_A750del	Non Small Cell Lung Cancer	gefitinib Sensitive: C3 – Early Trials gefitinib Sensitive : C3	gefitinib Sensitive: C3 – Early Trials gefitinib Sensitive : C3
EGFR E746_A750del	Non Small Cell Lung Cancer	EGFR E746_A750del	Non Small Cell Lung Cancer	osimertinib Sensitive: C3 – Early Trials osimertinib Sensitive : C3	osimertinib Sensitive: C3 – Early Trials osimertinib Sensitive : C3
EGFR E746_A750del	Non Small Cell Lung Cancer	EGFR E746_A750del	Non Small Cell Lung Cancer	Tyrosine kinase inhibitor Resistant: C3 – Early Trials Tyrosine kinase inhibitor Resistant : C3	Tyrosine kinase inhibitor Resistant: C3 – Early Trials Tyrosine kinase inhibitor Resistant : C3
EGFR E746_A750del	Lung Cancer	EGFR E746_A750del	Lung Cancer	afatinib Sensitive: C4 – Case Studies afatinib Sensitive : C4	afatinib Sensitive: C4 – Case Studies afatinib Sensitive : C4
EGFR E746_A750del	Non Small Cell Lung Cancer	EGFR E746_A750del	Non Small Cell Lung Cancer	neratinib Sensitive: D – Preclinical neratinib Sensitive : D	neratinib Sensitive: D – Preclinical neratinib Sensitive : D
EGFR E746_A750del	Non Small Cell Lung Cancer	EGFR E746_A750del	Non Small Cell Lung Cancer	MCLA-129 Sensitive: D – Preclinical MCLA-129 Sensitive : D	MCLA-129 Sensitive: D – Preclinical MCLA-129 Sensitive : D